K2: Research Roundup Hazard Recognition/Health Care

Julie Panko Moderator
ToxStrategies
Pittsburgh, PA 
 
Tina I En Chiang, MD, MSc OEH Author
Fraser Health Authority
Burnaby, BC 
Canada
 
James Weldy, CIH, CHP Author
Dow Chemical
Midland, MI 
United States of America
 
Wed, 5/22: 8:00 AM - 9:00 AM EDT
00527 
Research Roundup 
Greater Columbus Convention Center 
Room: A 210 
CM Credit Hours:

Content Level

Introductory
Intermediate

Organizational Category

Corporation/Company
Government/Military

Primary Industry

Healthcare/Pharma
Laboratories
Manufacturing

Topics

Available as part of AIHA CONNECT OnDemand
Exposure Banding/Occupational Exposure Limits
Hazard Recognition/Exposure Assessment
Healthcare
Risk Assessment and Management

Presentations

K2a. Closed System Drug Transfer Devices (CSTDs) for Hazardous Drugs

Occupational exposure to hazardous drugs is associated with reproductive toxic effects, genetic damage, and an increased risk for cancer. The primary route of healthcare workers' exposure is through dermal contact (e.g., contact with a drug vial/bag or contaminated surface. As an engineering control, closed-system drug transfer devices (CSTDs) have been proven to be effective in reducing the amount of drug contamination on surfaces by preventing aerosolization, leakage and spills. However, the use of CSTDs is currently not mandatory in British Columbia, Canada. The goal of this study was twofold: 1) obtain the perspectives and opinions of healthcare workers with respect to adopting the CSTDs process; and 2) evaluate the effectiveness of CSTDs in reducing drug contamination on work surfaces at multiple sites. This study is the largest research effort of its kind in British Columbia aimed at reducing hazardous drugs surface contamination levels. 

Co-Authors

CY Hon, Toronto Metropolitan University, Toronto, ON, Canada
JD Ellis, Fraser Health Authority, Surrey, BC, Canada
M Jeronimo, University of British Columbia, Vancouver, BC, Canada
DA Menard, University of Windsor, Windsor, ON, Canada
R Ciconte, Fraser Health Authority, Surrey, BC, Canada 

Acknowledgements & References

S Hejazi, Fraser Health Authority, Surrey, British Columbia, Canada – provided support in statistical analysis (for objective #1) 

Author

Tina I En Chiang, MD, MSc OEH, Fraser Health Authority Burnaby, BC 
Canada

K2b. Practical Application of TLV®-Surface Limits in a Safe Workplace

In recent years, the ACGIH has been publishing surface limits as exposure thresholds aimed at protecting workers from chemical hazards present on workplace surfaces. This case study will conduct exposure modeling for a number of real-world exposure scenarios to assess the amount of dermal exposure a worker will experience while interacting with workplace surfaces contaminated at levels equivalent to the TLV-Surface Limits®. Based on the results of this modeling, conclusions will be drawn on practical considerations to be used when implementing these new exposure limits. 

Co-Authors

none 

Acknowledgements & References

None 

Author

James Weldy, CIH, CHP, Dow Chemical Midland, MI 
United States of America